System and methods for the production of personalized drug products

A drug product, drug technology, applied in the direction of drugs or prescriptions, drug devices, drug devices, etc., can solve problems such as limited information on whether drugs are effective, lack of information, time of drug use for other factors of blood pressure, and undetermined exercise conditions.

Inactive Publication Date: 2013-08-14
INTELLIMEDICINE +1
View PDF14 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

As is common in current medical practice, patients may or may not have their blood pressure measured at home or in other settings, information on whether a drug is ultimately effective is limited or absent, and other factors affecting blood pressure (including medication time, exercise, diet) have not been determined

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • System and methods for the production of personalized drug products
  • System and methods for the production of personalized drug products
  • System and methods for the production of personalized drug products

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0111] Example: Use of a Personalized Combination Following Myocardial Infarction

[0112] For example, currently, the standard of care after acute myocardial infarction (AMI) includes the following medications:

[0113] 1. Aspirin, clopidogrel, beta blockers, statins, ACE inhibitors (treatment in the first year after myocardial infarction). We estimate that at least 1000 patients per million inhabitants per year take this combination.

[0114] 2. Aspirin, beta blockers, statins, ACE inhibitors (lifelong treatment)

[0115] The 2002 American College of Cardiology / American Heart Association guidelines for the management of unstable angina and non-ST-segment myocardial infarction, and the 2004 guidelines for the management of ST-segment myocardial infarction, with four key categories preferred for long-term administration Antiplatelet drugs, especially aspirin and clopidogrel, beta-blockers, angiotensin-converting enzyme inhibitors, and statins (PMID17701334).

[0116] In the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A system and method for determining an optimal combination drug product for a particular patient includes a processor that receives patient information and determines an optimal combination drug product based on the received information. A system which can provide information regarding predicted events or pathologies based on received patient information and guidance on subsequent steps to ameliorate, treat or intervent. A drug production device includes a plurality of drug containers, each of which are coupled to a drug dispensing channel. A controller controls the dispensing of drug through each channel, and a combination drug product is produced from the dispensed drugs. A combination drug product includes a plurality of discrete units of a first drug, and a plurality of discrete units of a second drug.; A transdermal patch includes a plurality of drug compartments, each containing a quantity of drug product, and a controller for controlling the release of drugs from each compartment. Feedback loop elements can enable iterations to optimized personalized doses.

Description

technical field [0001] The present invention relates to systems, methods and devices for recommending or administering the optimal treatment regimen and / or optimal drug selection, combination and dosage for a particular patient, in particular by utilizing patient information in conjunction with available medical and other relevant information and data sets to identify, predict, or recommend optimal drugs or treatments. The invention further relates to combination drug products, systems, ie methods and devices for delivery of combination drug products, and devices for containing quantities of drugs for use in drug production devices. In particular, the invention is used in the production of individually tailored pharmaceutical products, although other uses are also envisioned, and will be described in connection with such uses. Background technique [0002] Individual patients have unique needs for medicines and treatments, either for basic health (such as vitamins or other ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G06Q50/22B65D51/28G16H10/60G16Z99/00
CPCA61M35/00B65D51/2828G06Q50/22A61J1/03A61J3/074A61J2200/30A61J2205/60A61M2205/52A61M2205/6009A61M2205/6054G16H20/10Y02A90/10G16Z99/00
Inventor 丹尼尔·L·克拉夫特
Owner INTELLIMEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap